1. Home
  2. HDL vs INMD Comparison

HDL vs INMD Comparison

Compare HDL & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HDL

SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares

HOLD

Current Price

$13.41

Market Cap

829.7M

ML Signal

HOLD

Logo InMode Ltd.

INMD

InMode Ltd.

HOLD

Current Price

$13.75

Market Cap

842.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HDL
INMD
Founded
2016
2008
Country
Singapore
Israel
Employees
14003
N/A
Industry
Restaurants
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
829.7M
842.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
HDL
INMD
Price
$13.41
$13.75
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
$17.33
AVG Volume (30 Days)
2.3K
660.8K
Earning Date
05-20-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.73
$1.74
Revenue Next Year
$12.94
$3.26
P/E Ratio
$55.56
$10.11
Revenue Growth
N/A
N/A
52 Week Low
$13.31
$12.72
52 Week High
$23.62
$16.74

Technical Indicators

Market Signals
Indicator
HDL
INMD
Relative Strength Index (RSI) 38.04 43.81
Support Level $13.31 $13.47
Resistance Level $15.40 $13.87
Average True Range (ATR) 0.24 0.31
MACD -0.01 -0.08
Stochastic Oscillator 4.59 34.59

Price Performance

Historical Comparison
HDL
INMD

About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares

Super Hi International Holding Ltd is an investment holding company, and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. Its mission is to become a world-wide integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.

Share on Social Networks: